TRANSCODE THERAPEUTICS INC's ticker is RNAZ and the CUSIP is 89357L105. A total of 17 filers reported holding TRANSCODE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,121 | -74.8% | 21,019 | -50.0% | 0.00% | – |
| Q4 2022 | $28,292 | +23.0% | 42,038 | +100.0% | 0.00% | – |
| Q3 2022 | $23,000 | -11.5% | 21,019 | 0.0% | 0.00% | – |
| Q2 2022 | $26,000 | -57.4% | 21,019 | 0.0% | 0.00% | – |
| Q1 2022 | $61,000 | +17.3% | 21,019 | +2.0% | 0.00% | – |
| Q4 2021 | $52,000 | -16.1% | 20,600 | 0.0% | 0.00% | – |
| Q3 2021 | $62,000 | – | 20,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|